MedReps Reveals Medical Sales Professionals’ Top Choice Employers

A new survey by MedReps, a career site for medical sales representatives, revealed Teleflex, CONMED and Medtronic as the top three best large employers to work for. Avion and Acella Pharmaceuticals, 23andMe and Precision Medical were voted best small employers.

The 2022 Best Places to Work in Medical Sales report polled over 2,300 MedReps community professionals to identify which medical sales companies are currently the most sought-after in the industry.

The survey results also identified the qualities and values most important to medical sales reps today. Pay and leadership were on par for being the most important consideration in an employer, followed very closely by culture.

“Given the continued challenges medical sales reps faced in 2021, valuing leadership and culture in their place of work isn’t a surprise – and it’s important to recognize employers, like these companies on this list, that are doing much to support their employees,” said CEO Josh Goodwin. “We’re thrilled to highlight deserving employers to our community of medical sales professionals.”

“While COVID has certainly accelerated the creation of employee programs, Teleflex has always been committed to putting people at the center of all we do. It is part of our Core Values and is the heart and soul of our company, and it’s a prime reason our team is able to deliver on our commitments to healthcare professionals facing enormous challenges,” said Teleflex Corporate Vice President and Chief Human Resources Officer Cam Hicks, voted number one for large companies.

Speaking for Avion and Acella Pharmaceuticals, the top-voted small company, “Our leaders work and live through the philosophy of treating others the way they want to be treated,” said Avion Chief Executive Officer, Harold “Art” Deas.

To view the full list of top 10 large and top 10 small employers, click here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.